兹维特里奥尼克刷植接口生物滑剂避免了补充C3介导的巨细胞化,用于骨关节炎治疗
Chuandong Cai1, Mingwei Wang2,3, Luman Wang1,4
1Department of Orthopaedic Surgery, Zhongshan Hospital, Institute of Bone and Joint Diseases, Fudan University, Shanghai, 200032, China.
Advanced materials (Deerfield Beach, Fla.)
|April 30, 2025
概括
该研究开发了用于骨关节炎 (OA) 治疗的新型纳米颗粒,揭示了如何通过抑制补体C3结合来逃避巨细胞清除,从而增强滑和阻止疾病进展.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 治疗面临着由突巨细胞清除生物滑剂的挑战.
- 这种清除降低了治疗效果并引起炎症,部分原因是补充C3与纳米颗粒和CD11b对巨细胞的结合.
研究的目的:
- 开发一种基于纳米粒子的生物滑剂,可以避免巨细胞的清除,以有效治疗OA.
- 研究用于抑制巨细胞识别和C3吸附的接口修改.
主要方法:
- 对纳米粒子接口修改的系统评估.
- 在一个交叉连接的凝芯上植入一个zwitterionic poly-2-methacryloyloxyethyl phosphorylcholine (PMPC) 刷层.
- 在体外巨细胞化和极化试验.
- 在体内研究评估OA模型中的突炎症,疼痛和软骨退化.
主要成果:
- 该PMPC刷层显著抑制了C3吸附和巨细胞化.
- 在体外,纳米粒子阻止了M1极化和促炎性细胞因子的释放.
- 在体内,PMPC刷层减轻了炎症,减少了OA疼痛,并保护了软骨,阻止了OA的进展.
结论:
- 补充C3介导的巨细胞识别对于OA中纳米粒子清除至关重要.
- 使用PMPC刷的巨逃脱纳米粒子策略提供了一种有希望的方法来恢复关节滑和治疗骨关节炎.
相关概念视频
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...